Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02586077 · ClinicalTrials.gov registry record · Phase 4
Foot and Ankle Clinic Application for Liposomal Related Anesthetic
A Phase 4 study, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT02586077 is a Phase 4 study that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 36 participants.
The verdict
NCT02586077, a Phase 4 study, has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia. Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significantly impacted by the use of this modality.
Interventions
- DRUG Exparel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2016-11-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02586077
The ClinicalTrials.gov registry entry for NCT02586077 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoCarolina Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exparel is the first listed.
NCT02586077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02586077 about?
NCT02586077 is a clinical study titled "Foot and Ankle Clinic Application for Liposomal Related Anesthetic". The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia. Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significant...
What is the current status of trial NCT02586077?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2014-02-01. Estimated completion is 2016-11-15.
What interventions are being tested in trial NCT02586077?
The interventions under investigation include: Exparel (DRUG).
Who is sponsoring clinical trial NCT02586077?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.